fda warning glp-1 november 2025 From a new Perspective by Amanda Banks, MD: On February Generic GLP-1 medications: Current and ISPOR 2025: Exploring reasons for

Monitoring Potential Side Effects Despite its overall safety profile, semaglutide GLP-1 does have potential adverse effects, including digestive problems such as constipation, diarrhea, nausea, and abdominal discomfort

Foundayo (orforglipron) There had been just one oral GLP-1 option for weight loss the Wegovy pill but the FDA just approved a second one in April 2026: Foundayo (orforglipron), manufactured by Eli Lilly and Company

Special Features

Vitamin B12 is also important for DNA synthesis and your brain's and nerve cells' normal functions

Review them calmly, note any patterns or red flags, avoid making big DIY changes, and plan to share the report with your clinician to decide together what matters and what follow-up is needed. How do you use DTC testing alongside your regular healthcare